GSK-105-040

Study Sponsor: GSK

Study Title

A Multicenter, Double-Blind, Placebo-Controlled, Parallel-Design Evaluation of LAMICTAL for Add-on Treatment of Partial Seizures in Pediatric Patients

Medicine or Vaccine (generic name)

lamotrigine

Sponsor Identification Number

105-040

Trial Registry Identification Number(#'s)

Medical Condition

Epilepsy, Partial

Phase

Phase 3

Link to GSK Study Register

http://www.gsk-clinicalstudyregister.com/study/105-040

Link to study details on ClinicalTrials.gov (if available)

Link to study details on EudraCT (if available)

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report

Additional information about the data and documents available for this study

An analysis-ready dataset is not available for this study. A link to Clinicaltrials.gov and a NCT ID number are not available for this study because the study was conducted before regulatory requirements to register studies.

Date Added to this Site

March 2016